IC
EBS icon

IEQ Capital’s Emergent Biosolutions EBS Stock Holding History

IEQ Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Buy
51,333
+19,471
+61% +$202K ﹤0.01% 1372
2025
Q4 		$394K Sell
31,862
-2,446
-7% -$26.2K ﹤0.01% 1432
2025
Q3 		$303K Buy
+34,308
New +$267K ﹤0.01% 1524

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

IEQ Capital's EBS Position: Q1 2026 in Review

IEQ Capital increased its Emergent Biosolutions (EBS) stake by 61% in Q1 2026, buying an estimated $202K and bringing the position to 51,333 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

IEQ Capital first reported a position in EBS in Q3 2025 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • IEQ Capital held 51,333 shares of Emergent Biosolutions worth $426K as of Q1 2026.
  • IEQ Capital bought 19,471 Emergent Biosolutions shares in Q1 2026, an estimated $202K.
  • Emergent Biosolutions made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1372 holding.
  • IEQ Capital first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.